CYH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03
Preço $2.72
Capitalização de Mercado (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
Receita (TTM) $11.98B
ROE (TTM) -16.7%
Dívida/Capital (MRQ) -6.9
Intervalo 52 Semanas $2–$4

CYH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04
intervalo
barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Divisões de Ações 1
Data ex Desdobramento Tipo
22 de Abril de 2016 121-for-100 Para frente

Sobre Community Health Systems, Inc. Common Stock Visão geral da empresa da Wikipedia

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

setorHealth Care indústriaHealth Care funcionários44.000 paísUS

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06
Receita$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
Fluxo de caixa livre$208M
2016-12-31 → 2025-12-31
Margem líquida2.1%
2018-12-31 → 2025-12-31
Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica Tendência de 5 anos CYH média 5A Mediana de Pares Veredito
P/E (TTM) 1.5média 5A ≈3.4 ≈3.4 15.5 Subvalorizado
P/S (TTM) 0.0média 5A ≈0.1 ≈0.1 1.2 Subvalorizado
P/B (MRQ) -0.3média 5A ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.1média 5A ≈13.1 ≈13.1 10.6 Subvalorizado
Preço / FCF (TTM) -2.1média 5A ≈-0.8 ≈-0.8 · ·
Preço / Fluxo de Caixa (TTM) 3.0média 5A ≈-1.6 ≈-1.6 6.5 Subvalorizado
EV / Revenue (EV / Receita) 0.8média 5A ≈1.0 ≈1.0 · ·
EV / FCF 50.5média 5A ≈-4.9 ≈-4.9 · ·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

13
Data exValorMoedaRendimento
Dez 13, 2012$0,21USD≈0.84%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14
Surpresa Média 37.9%
Próximo relatório Out 21, 2026
PeríodoRelatórioEPS ActualEPS est.Surpresa
30 de Junho de 2026 Jul 21, 2026 $-0.19 $-0.06 -201.1%
31 de Março de 2026 $-0.48 $-0.10 -387.3%
31 de Dezembro de 2025 $-0.01 $-0.10 90.5%
30 de Setembro de 2025 $1.27 $-0.25 610.5%
30 de Junho de 2025 $-0.05 $-0.11 52.6%
31 de Março de 2025 $-0.03 $-0.08 62.6%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15
Demonstração de Resultados 13
Métrica Tendência 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Balanço Patrimonial 26
Métrica Tendência 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Fluxo de Caixa 13
Métrica Tendência 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Lucratividade 7
Métrica Tendência 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Liquidez e Solvência 4
Métrica Tendência 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Eficiência 2
Métrica Tendência 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Por Ação 5
Métrica Tendência 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Taxas de Crescimento 9
Métrica Tendência 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Avaliação (TTM) 13
Métrica Tendência 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $12.48B $12.63B $12.49B $12.21B $12.37B
Margem Operacional % 11.9% 4.3% 7.7% 6.7% 11.3%
Lucro líquido $509M $-516M $-133M $46M $230M
EPS Diluído $3.77 $-3.90 $-1.02 $0.35 $1.76

Investidores institucionais (13F) 196 declarantes · $415.1M total · Em 30 de Setembro de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 196
Valor detido $415.1M
Novas posições 31
Posições encerradas 24
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
31 (+9 vs trimestre anterior) 24 (+4 vs trimestre anterior) 69 (+6 vs trimestre anterior) 54 (-9 vs trimestre anterior) +7.0M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
CastleKnight Management LP $44.704.517 13.384.586 10,77% Ações
Apollo Management Holdings, L.P. $39.610.817 11.859.526 9,54% Ações
BlackRock, Inc. $36.507.995 10.930.538 8,79% Ações
VANGUARD GROUP INC $28.605.579 9.168.455 6,89% Ações
Eversept Partners, LP $26.267.680 7.864.575 6,33% Ações
NOMURA HOLDINGS INC $22.388.384 6.703.109 5,39% Ações
VANGUARD CAPITAL MANAGEMENT LLC $17.668.370 5.289.931 4,26% Ações
WHITEBOX ADVISORS LLC $12.467.362 3.732.743 3,00% Ações
GEODE CAPITAL MANAGEMENT, LLC $10.582.352 3.167.702 2,55% Ações
STATE STREET CORP $10.226.622 3.061.863 2,46% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $10.082.117 3.018.598 2,43% Ações
Saba Capital Management, L.P. $9.626.444 2.882.169 2,32% Ações
Owl Creek Asset Management, L.P. $8.452.277 2.530.622 2,04% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8.176.380 2.448.018 1,97% Ações
DIMENSIONAL FUND ADVISORS LP $7.854.253 2.351.460 1,89% Ações
D. E. Shaw & Co., Inc. $7.829.388 2.344.128 1,89% Ações
AQR CAPITAL MANAGEMENT LLC $7.651.362 2.290.827 1,84% Ações
TWO SIGMA INVESTMENTS, LP $7.365.822 2.205.336 1,77% Ações
Diameter Capital Partners LP $6.138.793 1.837.962 1,48% Ações
BANK OF AMERICA CORP /DE/ $5.903.847 1.767.619 1,42% Ações
GOLDMAN SACHS GROUP INC $5.868.073 1.756.908 1,41% Ações
TWO SIGMA ADVISERS, LP $5.816.476 1.864.255 1,40% Ações
CARRONADE CAPITAL MANAGEMENT, LP $5.230.000 1.565.847 1,26% Ações
Allianz Asset Management GmbH $5.167.919 1.547.281 1,24% Ações
MORGAN STANLEY $4.800.489 1.437.272 1,16% Ações
NORTHERN TRUST CORP $4.681.414 1.401.621 1,13% Ações
Silver Rock Financial LP $3.674.000 1.100.000 0,89% Ações
CITADEL ADVISORS LLC $3.475.360 1.040.527 0,84% Ações
Assenagon Asset Management S.A. $2.788.275 834.813 0,67% Ações
VANGUARD FIDUCIARY TRUST CO $2.642.231 791.087 0,64% Ações
Jefferies Financial Group Inc. $2.481.286 742.900 0,60% Ações
Alta Fundamental Advisers LLC $2.161.411 647.129 0,52% Ações
Bank of New York Mellon Corp $2.122.084 635.354 0,51% Ações
MARSHALL WACE, LLP $1.906.575 570.831 0,46% Ações
MILLENNIUM MANAGEMENT LLC $1.701.580 509.455 0,41% Ações
ExodusPoint Capital Management, LP $1.664.603 498.384 0,40% Ações
READYSTATE ASSET MANAGEMENT LP $1.657.729 496.326 0,40% Ações
WOLVERINE ASSET MANAGEMENT LLC $1.339.674 401.100 0,32% Opção de compra
Helix Partners Management LP $1.336.000 400.000 0,32% Ações
Susquehanna Portfolio Strategies, LLC $1.280.940 383.515 0,31% Ações
Voleon Capital Management LP $1.247.032 373.363 0,30% Ações
Invesco Ltd. $1.076.599 322.335 0,26% Ações
TUDOR INVESTMENT CORP ET AL $999.388 299.218 0,24% Ações
Pathstone Holdings, LLC $895.621 268.150 0,22% Ações
Prescott Group Capital Management, L.L.C. $863.076 258.406 0,21% Ações
UBS Group AG $851.089 254.817 0,21% Ações
MILLENNIUM MANAGEMENT LLC $835.000 250.000 0,20% Opção de venda
FEDERATED HERMES, INC. $812.599 243.293 0,20% Ações
LPL Financial LLC $737.239 220.730 0,18% Ações
IEQ CAPITAL, LLC $657.963 196.995 0,16% Ações

Mostrar todos os 196 proprietários institucionais →

Ativistas e proprietários de 5%+ 1 participação

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 declarações 11 de Março de 2021 · Declaração inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 56 insiders · 29 diretores · 23 conselheiros

19
Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Kevin J Hammons CEO 1 de Março de 2026 A 895.545 0 0 $0
Tim Hingtgen CEO 1 de Março de 2025 A 1.388.781 0 0 $0
Jason K Johnson EVP & CFO 1 de Março de 2026 A 268.439 0 0 $0
Thomas J Aaron EVP and CFO 7 de Dezembro de 2019 F 241.515 0 0 $0
Larry W Cash President and CFO 1 de Março de 2017 A 568.152 0 0 $0
Miguel S Benet President and CMO 1 de Março de 2025 D 47.635 0 0 $0
Austen D Mason Regional President 1 de Março de 2025 A 142.500 0 0 $0
Mark B Medley Regional President 1 de Março de 2025 A 128.637 0 0 $0
Chad A Campbell Regional President 1 de Março de 2025 A 136.815 0 0 $0
Charles J Cova Regional President 1 de Março de 2024 A 58.701 0 0 $0
Lynn T Simon President and CMO 1 de Março de 2024 A 482.657 0 0 $0
Beryl Ramsey Division President 1 de Março de 2019 A 62.969 0 0 $0
Patton Paul Smith Division President 1 de Março de 2019 F 119.017 0 0 $0
Iii John W Mcclellan Division President 1 de Março de 2017 A 41.242 0 0 $0
Robert O Horrar Division President 1 de Março de 2017 A 68.649 0 0 $0
Martin Bonick Division President 1 de Março de 2017 A 100.458 0 0 $0
Michael T Portacci Division President 1 de Março de 2017 A 110.156 0 0 $0
Thomas Daniel Miller Division President 1 de Março de 2016 A 112.107 0 0 $0
David Lewis Miller President and COO 1 de Março de 2016 A 440.840 0 0 $0
William S Hussey Division President 28 de Outubro de 2015 M 121.568 0 0 $0
Martin Dewayne Smith Division President 3 de Junho de 2015 M 94.111 0 0 $0
Gary D Newsome Division President - Group Ops 25 de Agosto de 2008 M 118.286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1 de Junho de 2026 A 30.000 0 0 $0
Phillip A. Posey SVP & CAO 1 de Março de 2026 A 51.736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1 de Março de 2026 A 287.750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1 de Março de 2026 A 208.290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1 de Março de 2017 F 243.065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 de Fevereiro de 2012 F 78.379 0 0 $0
Martin G Schweinhart Senior Vice President 1 de Março de 2006 A 40.354 0 0 $0
William Norris Jennings Conselheiro 25 de Agosto de 2026 S 38.468 0 1 $-118.400
Ranga K Krishnan Conselheiro 30 de Junho de 2026 M 170.023 0 0 $0
Fawn D Lopez Conselheiro 1 de Março de 2026 A · 0 0 $0
Ronald L Burgess JR Conselheiro 1 de Março de 2026 A · 0 0 $0
Susan W Brooks Conselheiro 1 de Março de 2026 A 108.695 0 0 $0
Hubert James Williams Conselheiro 1 de Março de 2026 A 211.863 0 0 $0
Joseph Arthur Hastings Conselheiro 1 de Março de 2026 A 0 0 0 $0
Elizabeth T Hirsch Conselheiro 1 de Março de 2026 A 162.059 0 0 $0
James S. Ely III Conselheiro 1 de Março de 2026 A 412.876 0 0 $0
John A Fry Conselheiro 1 de Março de 2026 A 268.966 0 0 $0
John A Clerico Conselheiro 1 de Março de 2026 A 368.763 0 0 $0
Michael Dinkins Conselheiro 1 de Março de 2026 A 225.882 0 0 $0
Wayne T Smith Conselheiro 1 de Março de 2026 A 5.217.579 0 0 $0
Julia B North Conselheiro 1 de Março de 2021 A 162.056 0 0 $0
Mitchell H Watson JR Conselheiro 16 de Maio de 2017 M 22.594 0 0 $0
Harvey Klein MD Conselheiro 15 de Março de 2010 M 10.383 0 0 $0
Dale F Frey Conselheiro 31 de Março de 2008 A 20.000 0 0 $0
Thomas H Lister Conselheiro 21 de Setembro de 2004 S 0 0 0 $0
Thodore Forstmann Conselheiro 21 de Setembro de 2004 S 0 0 0 $0
Sandra Horbach Conselheiro 21 de Setembro de 2004 S 0 0 0 $0
Robert J Dole Conselheiro 6 de Maio de 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP Detentor de 10% 21 de Setembro de 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP Detentor de 10% 21 de Setembro de 2004 S 0 0 0 $0
Winston Hutchins Detentor de 10% 21 de Setembro de 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP Detentor de 10% 21 de Setembro de 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P Detentor de 10% 21 de Setembro de 2004 S 0 0 0 $0
Benjamin C Fordham · 1 de Março de 2021 A 254.608 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 25 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
BSJR · Invesco Exchange-Traded Self-Indexe… 2,85% 24.817.000 2 de Outubro de 2026 Diário
EBIT · Harbor ETF Trust 0,45% 19.210 NS 31 de Julho de 2026 N-PORT
IWC · iShares Trust 0,09% 443.690 SH 11 de Setembro de 2026 Diário
IHF · iShares Trust 0,05% 223.947 SH 11 de Setembro de 2026 Diário
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113.109 SH 19 de Agosto de 2026 Diário
NEAR · iShares U.S. ETF Trust 0,03% 1.340.000 SH 11 de Setembro de 2026 Diário
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 221.871 SH 2 de Outubro de 2026 Diário
IWM · iShares Trust 0,01% 3.425.206 SH 11 de Setembro de 2026 Diário
RSSL · Global X Funds 0,01% 62.038 NS 31 de Julho de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746.733 SH 19 de Agosto de 2026 Diário
VHT · VANGUARD WORLD FUND 0,01% 349.881 SH 19 de Agosto de 2026 Diário
DFAS · Dimensional ETF Trust 0,01% 289.348 NS 31 de Julho de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202.789 NS 31 de Julho de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33.838 NS 31 de Julho de 2026 N-PORT
ITOT · iShares Trust 0,00% 203.848 SH 11 de Setembro de 2026 Diário
IWV · iShares Trust 0,00% 42.177 SH 3 de Setembro de 2026 Diário
DCOR · Dimensional ETF Trust 0,00% 6.184 NS 31 de Julho de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31.135 NS 31 de Julho de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1.347.195 SH 19 de Agosto de 2026 Diário
VTI · VANGUARD INDEX FUNDS 0,00% 3.813.888 SH 19 de Agosto de 2026 Diário
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9.817 SH 19 de Agosto de 2026 Diário
DFSU · Dimensional ETF Trust 0,00% 24 NS 31 de Julho de 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 de Julho de 2026 Diário
VPLS · VANGUARD MALVERN FUNDS · · 15 de Julho de 2026 Diário
IWN · iShares Trust · 1.223.127 SH 11 de Setembro de 2026 Diário

CYH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21
classificação · 16 analistas MANTER
Alvo mediano $3.12 +14,9%
1 6,2% Compra forte
1 6,2% Compra
6 37,5% Manter
7 43,8% Venda
1 6,2% Venda forte

Preço-alvo de 12 meses

8 analistas · 2026-10-01

Alvo médio $3.16 +16,0%

Agora Preço atual $2.72
Mín$2.00 Média$3.16 Máx$4.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Últimas notícias Notícias recentes mencionando esta empresa

23

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Fonte: SEC 10-Q arquivado Jul 23, 2026